Form F-6 - Registration of American Depository Receipt shares, not immediately effective:
SEC Accession No. 0001193805-21-000697
Filing Date
2021-05-21
Accepted
2021-05-21 16:38:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 e620619_f6-centessa.htm F-6 60740
2 e620619_ex99-a.htm EX-99.(A) 454776
3 e620619_ex99-d.htm EX-99.(D) 6663
4 GRAPHIC logo.jpg GRAPHIC 18700
  Complete submission text file 0001193805-21-000697.txt   549627
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

EIN.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6

Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals Ltd (Subject) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-6 | Act: 33 | File No.: 333-256385 | Film No.: 21949652
SIC: 2834 Pharmaceutical Preparations